Mid-Day Market Update: Crude Oil Down Over 1%; Intellia Therapeutics Shares Jump
Midway through trading Monday, the Dow traded down 0.52% to 34,253.86 while the NASDAQ rose 0.72% to 14,463.56. The S&P also fell, dropping 0.01% to 4,280.50.
44 Stocks Moving In Monday’s Mid-Day Session
Gainers
Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy.
UPDATE: CEL-SCI Earlier Release Showed Co. When Its Multikine Treatment Was Administered And Higher Risk Was Compared To Control, Study Did Not Achieve Its Primary Endpoint
When the complete study population to which the Multikine treatment regimen was administered (i.e., the combined lower risk (no chemotherapy) and higher risk (with chemotherapy added)) was compared to control, the study
Mid-Morning Market Update: Markets Mixed; Perion Network Boosts FY21 Outlook
Following the market opening Monday, the Dow traded down 0.30% to 34,329.01 while the NASDAQ rose 0.60% to 14,446.74. The S&P also rose, gaining 0.04% to 4,282.58.
CEL-SCI’s Immunotherapy Achieves Survival Benefit Of 14% Exceeding Pre-Defined 10% In Head & Cancer Patients
CEL-SCI Corporation (NYSE:CVM) has announced results from its Phase 3 study for its immunotherapy Multikine for advanced previously untreated squamous cell…
CEL-SCI Says Co’s Multikine Immunotherapy Produces 14.1% 5-Year Survival Benefit (62.7% Vs 48.6%) In The Group Receiving Surgery Plus Radiotherapy In Head And Neck Cancer Phase 3 Study
CEL-SCI Corporation (NYSE:CVM) today announced results from its 9.5 year pivotal Phase 3 study for its immunotherapy Multikine® (Leukocyte Interleukin, Injection)* in the treatment of advanced (stages
58 Biggest Movers From Yesterday
Gainers
Peabody Energy Corporation (NYSE: BTU) shares gained 32.3% to settle at $8.60 on Monday.
70 Biggest Movers From Yesterday
Gainers Genprex, Inc. (NASDAQ:GNPX) shares surged 64.4% to close at $1.89 on Wednesday after climbing 219.44% on Tuesday.…
46 Stocks Moving In Wednesday’s Mid-Day Session
Gainers Neurotrope, Inc. (NASDAQ:NTRP) shares jumped 114.5% to $3.11 after the company announced it was awarded $2.7 million…